Brain accumulation of the EML4-ALK inhibitor ceritinib is restricted by P-glycoprotein (P-GP/ABCB1) and breast cancer resistance protein (BCRP/ABCG2) - Kort, A; Sparidans, R W; Wagenaar, E; Beijnen, J H; Schinkel, A H (Pharmacol Res, 2015)